Do you want to read an article? Please log in or register.
Quantitative analysis of optical coherence tomography for neovascular age-related macular degeneration using deep learning
Macular Diseases
Related content
COMMENTED
Macular Diseases
Advanced optical coherence tomography angiography analysis of age-related macular degeneration complicated by onset of unilateral choroidal neovascularization
Am J Ophthalmol.
Arrigo A, Aragona E, Capone L, Pierro L, Romano F, Bandello F, Parodi MB
doi: 10.1016/j.ajo.2018.08.001.
Macular Diseases
Feasibility of support vector machine learning in age-related macular degeneration using small sample yielding sparse optical coherence tomography data
Acta Ophthalmol.
Quellec G, Kowal J, Hasler PW, Scholl HPN, Zweifel S, Konstantinos B, de Carvalho JER, Heeren T, Egan C,
Tufail A, Maloca PM
doi: 10.1111/aos.14055.
Macular Diseases
Swept-source optical coherence tomography angiography features of subretinal fibrosis in neovascular age-related macular degeneration
Clin Exp Ophthalmol.
Balaskas K, Ali ZC, Saddik T, Gemenetzi M, Patel P, Aslam TM
doi: 10.1111/ceo.13367.
Macular Diseases
Characterization of Drusen and Hyperreflective Foci as Biomarkers for Disease Progression in Age-Related Macular Degeneration Using Artificial Intelligence in Optical Coherence Tomography
JAMA Ophthalmol.
Waldstein SM, Vogl WD, Bogunovic H, Sadeghipour A, Riedl S, Schmidt-Erfurth U
doi: 10.1001/jamaophthalmol.2020.1376.
Macular Diseases
Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trial
JAMA Ophthalmol.
Ramakrishnan MS, Yu Y, VanderBeek BL
doi: 10.1001/jamaophthalmol.2019.4577.
Macular Diseases
Association Between Cilioretinal Arteries and Advanced Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT)
JAMA Ophthalmol.
Bavinger JC, Ying GS, Daniel E, Grunwald JE, Maguire MG, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.
doi: 10.1001/jamaophthalmol.
Macular Diseases
ASSESSMENT OF EARLY CHANGES IN SPECTRAL DOMAIN-OPTICAL COHERENCE TOMOGRAPHY AFTER INITIATION OF TREATMENT WITH INTRAVITREAL AFLIBERCEPT (EYLEA) OVER A 12-WEEK PERIOD FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Multicenter French Study (START)
Retina
Korobelnik JF, Souied EH, Oubraham H, Razavi S, Mauget-Faÿsse M, Savel H, Chene G, Wolf S
doi: 10.1097/IAE.0000000000002910
COMMENTED
Macular Diseases
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group
★ 3
Recommended by
Prof. Dr Daniel Barthelmes, Faculty Member
★ 3
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
doi: 10.1016/j.ophtha.2019.11.004.
COMMENTED
Macular Diseases
Use of Deep Learning for Detailed Severity Characterization and Estimation of 5-Year Risk Among Patients With Age-Related Macular Degeneration
JAMA Ophthalmol.
Burlina PM, Joshi N, Pacheco KD, Freund DE, Kong J, Bressler NM
doi: 10.1001/jamaophthalmol.